
doi: 10.1007/bf02776628
pmid: 6536588
There have been major advances in the understanding of pathogenesis and management of hemolytic uremic syndrome in the last decade. Since the consensus paper published in 2009 by the European Pediatric Study Group in 2009, there have been four prospective trials and multiple case reports on effective terminal blockade with Eculizumab, an international consensus on the diagnostic and therapeutic strategies for management has been published in 2015.
Male, Anemia, Hemolytic, Infant, Disseminated Intravascular Coagulation, Prognosis, Thrombocytopenia, Diagnosis, Differential, Child, Preschool, Hemolytic-Uremic Syndrome, Humans, Female, Blood Coagulation Tests, Child
Male, Anemia, Hemolytic, Infant, Disseminated Intravascular Coagulation, Prognosis, Thrombocytopenia, Diagnosis, Differential, Child, Preschool, Hemolytic-Uremic Syndrome, Humans, Female, Blood Coagulation Tests, Child
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
